ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$14.21 USD
-0.45 (-3.07%)
Updated May 17, 2024 04:00 PM ET
After-Market: $14.21 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALXO 14.21 -0.45(-3.07%)
Will ALXO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
Wall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and Moderna
Biotech Stock Roundup: NVAX Up on Updates, ALXO Gains on Study Data & More
Other News for ALXO
Insider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), ALX Oncology Holdings (ALXO) and Quoin Pharmaceuticals (QNRX)
Piper Sandler Sticks to Its Buy Rating for ALX Oncology Holdings (ALXO)
ALX Oncology price target raised by $5 at H.C. Wainwright, here's why